Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Robertson

Showing results (691-700 of 715) with videos related to

Pageof 72
Sort By:
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Science (New York, N.Y.)|January 21, 2017
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceJosé J Fuster, Susan MacLauchlan, María A Zuriaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2022
Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer CentersJakob D Jensen, Jackilen Shannon, Ronaldo Iachan, et al.
Arthritis Research & Therapy|September 2, 2014
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destructionClaire J Greenhill, Gareth W Jones, Mari A Nowell, et al.
Cardiovascular Research|October 31, 2021
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosisJan Hettwer, Julia Hinterdobler, Benedikt Miritsch, et al.
The Journal of Experimental Medicine|May 11, 2017
Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasomeViola Neudecker, Moritz Haneklaus, Owen Jensen, et al.
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
British Journal of Pharmacology|June 24, 2015
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in miceS M Krishnan, J K Dowling, Y H Ling, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Journal of Leukocyte Biology|June 13, 2020
Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophagesSeong H Chow, Pankaj Deo, Amy T Y Yeung, et al.
Pageof 72

Showing results (691-700 of 715) with videos related to

Sort By:
Pageof 72
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Science (New York, N.Y.)|January 21, 2017
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceJosé J Fuster, Susan MacLauchlan, María A Zuriaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2022
Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer CentersJakob D Jensen, Jackilen Shannon, Ronaldo Iachan, et al.
Arthritis Research & Therapy|September 2, 2014
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destructionClaire J Greenhill, Gareth W Jones, Mari A Nowell, et al.
Cardiovascular Research|October 31, 2021
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosisJan Hettwer, Julia Hinterdobler, Benedikt Miritsch, et al.
The Journal of Experimental Medicine|May 11, 2017
Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasomeViola Neudecker, Moritz Haneklaus, Owen Jensen, et al.
Cardiovascular Research|October 26, 2018
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertensionShalini M Krishnan, Yeong H Ling, Brooke M Huuskes, et al.
British Journal of Pharmacology|June 24, 2015
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in miceS M Krishnan, J K Dowling, Y H Ling, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Journal of Leukocyte Biology|June 13, 2020
Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophagesSeong H Chow, Pankaj Deo, Amy T Y Yeung, et al.
Pageof 72